Department of Thoracic Surgery, The second affiliated hospital of AFMU, Air Force Medical University, Xi'an, 710038, China.
Turk J Gastroenterol. 2020 Dec;31(12):948-954. doi: 10.5152/tjg.2020.19757.
BACKGROUND/AIMS: There is no consensus on treatment for cervical esophageal squamous cell carcinoma (ESCC). Our aim is to evaluate the feasibility and outcome of larynx-preserving limited resection with total thoracic esophagectomy and gastric pull-up reconstruction for the treatment of cervical ESCC without tumor involvement of the larynx and hypopharynx.
Retrospective analysis of patients with cervical ESCC who underwent R0 surgical resection from 2006 to 2011 in our center was performed. Kaplan-Meier method was used to calculate the survival time for patients.
In total, 74 cervical ESCC patients were enrolled in the study. The mortality rate in 30 days was 8.1%, the total complication rate (at least one) was 47.3%, anastomosis leakage occurrence was 37.8%, mechanical ventilation ratewas12.2%, the rate of normal oral diet within 15 days was 71.6%, and the anastomosis recurrence rate in follow-up was 8.1%. Detailed analysis showed that the anastomosis leakage, pulmonary infection, laryngeal recurrent nerve injury, and chylothorax were the most common complications in surgical patients. Finally, the survival data showed that the median survival time was 31.83 months (95% CI=12.39-51.28 months) and the 3-year and 5-year survival rates were 49.1% and 35.5%, respectively.
Larynx-preserving limited resection with total thoracic esophagectomy and gastric pull-up reconstruction might be a feasible and effective surgical alternative for the cervical ESCC patients whose tumor does not involve the larynx and hypopharynx.
背景/目的:对于颈段食管鳞癌(ESCC),目前尚无统一的治疗方法。本研究旨在评估保留喉的局限性颈段食管 ESCC 切除术联合全胸段食管切除、胃上提重建术的可行性及疗效,且肿瘤未累及喉及下咽。
回顾性分析 2006 年至 2011 年在我院接受 R0 手术切除的颈段 ESCC 患者。采用 Kaplan-Meier 法计算患者的生存时间。
共纳入 74 例颈段 ESCC 患者,术后 30 天死亡率为 8.1%,总并发症发生率(至少一种)为 47.3%,吻合口漏发生率为 37.8%,机械通气率为 12.2%,术后 15 天内恢复正常经口饮食的比例为 71.6%,随访中吻合口复发率为 8.1%。详细分析显示,手术患者中最常见的并发症是吻合口漏、肺部感染、喉返神经损伤和乳糜胸。最终,生存数据显示,中位生存时间为 31.83 个月(95%CI=12.39-51.28 个月),3 年和 5 年生存率分别为 49.1%和 35.5%。
对于肿瘤未累及喉及下咽的颈段 ESCC 患者,保留喉的局限性颈段食管 ESCC 切除术联合全胸段食管切除、胃上提重建术可能是一种可行且有效的手术选择。